U.S., May 14 -- ClinicalTrials.gov registry received information related to the study (NCT06968312) titled 'Hexadecanal as an Addon to Cognitive Processing Therapy for PTSD' on May 05.
Brief Summary: This RCT investigates whether Cognitive Processing Therapy, a first line treatment for PTSD, can be enhanced by the use of the odor molecule Hexadecenal (HEX). HEX is secreted from body odor and has been shown to promotes psychological well-being and positive social interaction. For the active group Hex will be diffused in the treatment room during all treatment sessions. For the control group a vehicle placebo molecule will be diffused. Both therapists and patients will be blind to study condition.
Study Start Date: May 05
Study Type: INTER...